“…Escober et al demonstrated that the nuclear factor-kappa B inhibitor N-[3,5-Bis(trifluoromethyl) phenyl]-5-chloro-2-hydroxybenzamide at sub-MIC of 0.0313 μg/mL can inhibit the initial cell attachment and biofilm formation of vancomycin-resistant S. aureus strain VRS1 in a dose-dependent manner [68] . The sub-MICs of other antimicrobial compounds, such as N-nonyloxypentyl-L-DNJ, N4-benzyl-N-2-phenylquinazoline-2,4-diamine, terpenoid (+)-nootkatone, chitosan, marine steroid siphonocholin, zinc oxide, and silver nanoparticles, are found to be able to inhibit the biofilm formation of diverse S. aureus strains [43] , [46] , [69] , [70] , [71] , [89] .…”